1. Home
  2. WAT vs BCH Comparison

WAT vs BCH Comparison

Compare WAT & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • BCH
  • Stock Information
  • Founded
  • WAT 1958
  • BCH 1893
  • Country
  • WAT United States
  • BCH Chile
  • Employees
  • WAT N/A
  • BCH N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • BCH Commercial Banks
  • Sector
  • WAT Industrials
  • BCH Finance
  • Exchange
  • WAT Nasdaq
  • BCH Nasdaq
  • Market Cap
  • WAT 17.4B
  • BCH 15.0B
  • IPO Year
  • WAT 1995
  • BCH 2002
  • Fundamental
  • Price
  • WAT $372.49
  • BCH $35.86
  • Analyst Decision
  • WAT Buy
  • BCH Hold
  • Analyst Count
  • WAT 12
  • BCH 2
  • Target Price
  • WAT $372.25
  • BCH $28.00
  • AVG Volume (30 Days)
  • WAT 685.5K
  • BCH 302.4K
  • Earning Date
  • WAT 11-04-2025
  • BCH 10-30-2025
  • Dividend Yield
  • WAT N/A
  • BCH 4.45%
  • EPS Growth
  • WAT 3.82
  • BCH N/A
  • EPS
  • WAT 10.88
  • BCH 0.01
  • Revenue
  • WAT $3,105,638,000.00
  • BCH $2,793,481,720.00
  • Revenue This Year
  • WAT $7.12
  • BCH $18.25
  • Revenue Next Year
  • WAT $6.22
  • BCH $5.09
  • P/E Ratio
  • WAT $33.77
  • BCH $13.88
  • Revenue Growth
  • WAT 6.90
  • BCH N/A
  • 52 Week Low
  • WAT $275.05
  • BCH $22.06
  • 52 Week High
  • WAT $423.56
  • BCH $36.11
  • Technical
  • Relative Strength Index (RSI)
  • WAT 70.28
  • BCH 71.71
  • Support Level
  • WAT $340.09
  • BCH $34.15
  • Resistance Level
  • WAT $382.02
  • BCH $36.06
  • Average True Range (ATR)
  • WAT 11.43
  • BCH 0.57
  • MACD
  • WAT 0.58
  • BCH 0.15
  • Stochastic Oscillator
  • WAT 71.99
  • BCH 87.53

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About BCH Banco De Chile ADS

Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.

Share on Social Networks: